Progenics Pharma (PGNX) Posts Narrower than Expected Q4 Loss
Tweet Send to a Friend
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) reported Q4 EPS of ($0.01) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
